During the past decade, Clinique des Voies Respiratoires, Hôpital Larrey conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique des Voies Respiratoires, Hôpital Larrey" #1 collaborator was "Signia Therapeutics" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Clinique des Voies Respiratoires, Hôpital Larrey" are "COVID-19" (1 trials) and "Stage 4 Pulmonary Sarcoidosis" (1 trials). Many other conditions were trialed in "Clinique des Voies Respiratoires, Hôpital Larrey" in a lesser frequency.

Most popular intervention types in "Clinique des Voies Respiratoires, Hôpital Larrey" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "DILTIAZEM TEVA 60 mg or placebo" (1 trials) and "Pulmonary rehabilitation program" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique des Voies Respiratoires, Hôpital Larrey" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Clinique des Voies Respiratoires, Hôpital Larrey". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Clinique des Voies Respiratoires, Hôpital Larrey, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique des Voies Respiratoires, Hôpital Larrey, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".